Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,901.36
+1.17
(
+0.03%
)
Dow 30
0.00%
QQQ
-0.36%
VIX
29.43
+0.08
(
+0.27%
)
Merrimack Pharmaceuticals Inc
NASDAQ:MACK
5.34
+0.08
(
+1.62%
)
Earnings Announcements
Merrimack Reports First Quarter 2022 Financial Results
Published: 05/05/2022 20:44 GMT
MACK
Merrimack Pharmaceuticals Inc (
MACK
)
- Merrimack Reports First Quarter 2022 Financial Results.
Reported a Net Loss of $132 Thousand for Q1 Ended March 31, 2022, Or $0.01 per Basic and Diluted Share.